Dynamis DNP is Bruker BioSpin’s dissolution hyperpolarizer for preclinical carbon-13 metabolic MRI and solution NMR.
Competing Products
Bruker BioSpin
Leading global provider of magnetic resonance and preclinical imaging instruments.
Founded
1960Leading global provider of magnetic resonance and preclinical imaging instruments.
Founded by Prof. Günther Laukien, Bruker BioSpin is a leading global provider of magnetic resonance and preclinical imaging instruments. The company’s core mission is to enable high-value life science research and diagnostics solutions, with a vision to advance scientific understanding and improve human health. Bruker BioSpin offers a comprehensive range of products, including spatial biology and single-cell analysis tools, biopharma and applied solutions, and advanced neuro research technologies. Their market focus spans life sciences, diagnostics, and various applied research fields.
Notable affiliated individuals include the founder, Prof. Günther Laukien, whose legacy continues to influence the company's innovative direction. Bruker BioSpin has achieved significant milestones, such as the development of groundbreaking instruments like the timsTOF Ultra and neofleX™. Their impact is evident in the advancement of neuro research and immuno-oncology, among other areas. The company’s contributions have solidified its reputation as a pivotal player in the scientific community, driving forward both academic and applied research globally.
Companies similar to Bruker BioSpin include Polarize, NVision, Bruker and Bio-Rad.
Bruker BioSpin was founded in 1960.
Bruker BioSpin's headquarters is located in Billerica, MA, US.
As of Dec 12, 2019, Bruker BioSpin has disclosed funding of $22.5M (USD). Undisclosed round amounts are excluded.
Bruker BioSpin has 7,500 employees as of Feb 10, 2024.
bio-rad.com